스트레스성 위장궤양 예방치료제 처방남용에 대한 의료전문가의 인식과 지식 분석

키워드

참고문헌 (38)

1. Grube RR., "Stress ulcer prophylaxis in hospitalized patients not in intensive care units", Am J Health Syst Pharm, 64(13), pp.1396~1400 (2007)
2. ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis, "ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 14, 1998", Am J Health Syst Pharm, 56(4), pp.347~379 (1999)
3. Choung RS., "Epidemiology and clinical presentation of stress-related peptic damage and chronic peptic ulcer", Curr Mol Med, 8, pp.253~257 (2008)
4. Andersson B., "Gastrointestinal complications after cardiac surgery", Br J Surg, 92, pp.326~333 (2005)
5. Faisy C., "Clinically significant gastrointestinal bleeding in critically ill patients with and without stress-ulcer prophylaxis", Intensive Care Med, 29(8), pp.1306~1313 (2003)
6. Dellinger RP., "Surviving Sepsis Campaign : international guidelines for management of severe sepsis and septic shock, 2012", Intensive Care Med, 39(2), pp.165~228 (2013)
7. Spirt MJ., "Update on stress ulcer prophylaxis in critically ill patients", Crit Care Nurse, 26(1), pp.18~20 (2006)
8. Cook DJ., "The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients", Crit Care, 5(6), pp.368~375 (2001)
9. Thomas L., "Longitudinal analysis of the costs associated with inpatient initiation and subsequent outpatient continuation of proton pump inhibitor therapy for stress ulcer prophylaxis in a large managed care organization", J Manag Care Pharm, 16(2), pp.122~129 (2010)
10. Herzig SJ., "Acid-suppressive medication use and the risk for nosocomial gastrointestinal tract bleeding", Arch Intern Med, 171(11), pp.991~997 (2011)
11. Heidelbaugh JJ., "Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients", Am J Gastroenterol, 101(10), pp.2200~2205 (2006)
12. Gardner TB., "Stress ulcer prophylaxis in non-critically ill patients : less may be more", Am J Gastroenterol, 101(10), pp.2206~2208 (2006)
13. Nardino RJ., "Overuse of acid-suppressive therapy in hospitalized patients", Am J Gastroenterol, 95(11), pp.3118~3122 (2000)
14. Shin S, "Evaluation of costs accrued through inadvertent continuation of hospital-initiated proton pump inhibitor therapy for stress ulcer prophylaxis beyond hospital discharge : a retrospective chart review", Ther Clin Risk Manag, 11, pp.649~657 (2015)
15. Cook DJ., "Canadian Critical Care Trials Group", N Engl J Med, 330(6), pp.377~381 (1994)
16. Alhazzani W., "Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients : a systematic review and meta-analysis", Crit Care Med, 41(3), pp.693~705 (2013)
17. Lin PC., "The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients : a meta-analysis", Crit Care Med, 38(4), pp.1197~1205 (2010)
18. Barkun AN., "Proton pump inhibitors vs. histamine 2 receptor antagonists for stress-related mucosal bleeding prophylaxis in critically ill patients: a meta-analysis", Am J Gastroenterol, 107(4), pp.507~520 (2012)
19. Barletta JF., "Use of proton pump inhibitors for the provision of stress ulcer prophylaxis : clinical and economic consequences", Pharmacoeconomics, 32(1), pp.5~13 (2014)
20. Zeigler AJ., "Medication reconciliation effect on prolonged inpatient stress ulcer prophylaxis", Ann Pharmacother, 42(7), pp.940~946 (2008)
21. Murphy CE., "Frequency of inappropriate continuation of acid suppressive therapy after discharge in patients who began therapy in the surgical intensive care unit", Pharmacotherapy, 28(8), pp.968~976 (2008)
22. Wohlt PD., "Inappropriate continuation of stress ulcer prophylactic therapy after discharge", Ann Pharmacother, 41(10), pp.1611~1616 (2007)
23. Hatch JB., "Stress ulcer prophylaxis : reducing nonindicated prescribing after hospital discharge", Ann of Pharmacother, 44(10), pp.1565~1571 (2010)
24. Hussain S., "Why do physicians prescribe stress ulcer prophylaxis to general medicine patients?", South Med J, 103(11), pp.1103~1110 (2010)
25. Koczka CP., "Physicians' opinions of stress ulcer prophylaxis : survey results from a large urban medical center", Dig Dis Sci, 58(3), pp.777~781 (2013)
26. Dial S., "Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease", JAMA, 294(23), pp.2989~2995 (2005)
27. Dial S., "Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy", CMAJ, 175(7), pp.745~748 (2006)
28. Cook DJ., "Stress ulcer prophylaxis: gastrointestinal bleeding and nosocomial pneumonia. Best evidence synthesis", Scand J Gastroenterol Suppl, 210, pp.48~52 (1995)
29. Laheij RJ., "Risk of communityacquired pneumonia and use of gastric acid-suppressive drugs", JAMA, 292(16), pp.1955~1960 (2004)
30. Herzig SJ., "Acid-suppressive medication use and the risk for hospital-acquired pneumonia", JAMA, 301(20), pp.2120~2128 (2009)
31. Laine L., "Proton pump inhibitors and bone fractures?", Am J Gastroenterol, 104(Suppl 2), pp.S21~S26 (2009)
32. Yang YX, "Proton pump inhibitor therapy and osteoporosis", Curr Drug Saf, 3(3), pp.204~209 (2008)
33. Jayatilaka S., "Clostridium difficile infection in an urban medical center : five-year analysis of infection rates among adult admissions and association with the use of proton pump inhibitors", Ann Clin Lab Sci, 37(3), pp.241~247 (2007)
34. Thorens J., "Bacterial overgrowth during treatment with omeprazole compared with cimetidine : a prospective randomised double blind study", Gut, 39(1), pp.54~59 (1996)
35. Zedtwitz-Liebenstein K., "Omeprazole treatment diminishes intra-and extracellular neutrophil reactive oxygen production and bactericidal acitivity", Crit Care Med, 30(5), pp.1118~1122 (2002)
36. Tasaka CL., "An interprofessional approach to reducing the overutilization of stress ulcer prophylaxis in adult medical and surgical intensive care units", Ann Pharmacother, 48(4), pp.462~469 (2014)
37. Pitimana-aree S., "Implementation of a clinical practice guideline for stress ulcer prophylaxis increases appropriateness and decreases cost of care", Intensive Care Med, 24(3), pp.217~223 (1998)
38. Khalili H., "Descriptive analysis of a clinical pharmacy intervention to improve the appropriate use of stress ulcer prophylaxis in a hospital infectious disease ward", J Manag Care Pharm, 16(2), pp.114~121 (2010)

관련 논문AI추천